These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11578682)

  • 1. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
    McManus K; Tait GR; Bellavance F; Le Mellédo JM
    J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin.
    Tait GR; McManus K; Bellavance F; Lara N; Chrapko W; Le Mellédo JM
    Psychoneuroendocrinology; 2002 May; 27(4):417-29. PubMed ID: 11911996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.
    Le Melledo JM; Perez-Parada J; Morrow J; Bellavance F; Lara N; Jahandar F; Granger R; Tait G; McManus K
    J Psychopharmacol; 2011 Jan; 25(1):71-7. PubMed ID: 19825898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.
    Morrow JD; McManus K; Tait GR; Bellavance F; Chrapko W; Lara N; Le Mellédo JM
    J Psychiatry Neurosci; 2003 Mar; 28(2):127-33. PubMed ID: 12670129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK?
    Coupland N; Malizia A; Bailey J; Nutt D
    Biol Psychiatry; 1996 Mar; 39(6):465-6. PubMed ID: 8679797
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder.
    Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N
    Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
    Abelson JL; Nesse RM; Vinik AI
    Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
    Zedkova L; Coupland NJ; Man GC; Dinsa G; Sanghera G
    Depress Anxiety; 2003; 17(2):78-87. PubMed ID: 12621596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
    Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
    McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
    Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD; Slate SO; Geraci M; Uhde TW
    Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.
    van Vliet IM; Westenberg HG; Slaap BR; den Boer JA; Ho Pian KL
    Biol Psychiatry; 1997 Jul; 42(1):76-8. PubMed ID: 9193745
    [No Abstract]   [Full Text] [Related]  

  • 14. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
    Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks.
    Lara N; Chrapko WE; Archer SL; Bellavance F; Mayers I; Le Mellédo JM
    Neuropsychopharmacology; 2003 Oct; 28(10):1840-5. PubMed ID: 12865901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.
    Coupland N; Zedkova L; Sanghera G; Leyton M; Le Mellédo JM
    J Psychiatry Neurosci; 2001 May; 26(3):247-51. PubMed ID: 11394194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4.
    Le Mellédo JM; Arthur H; Dalton J; Woo C; Lipton N; Bellavance F; Koszycki D; Boulenger JP; Bradwejn J
    J Psychosom Res; 2001 Sep; 51(3):513-20. PubMed ID: 11602221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal.
    Geraci M; Anderson TS; Slate-Cothren S; Post RM; McCann UD
    Biol Psychiatry; 2002 Dec; 52(12):1183-9. PubMed ID: 12488064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
    de Leeuw AS; Den Boer JA; Slaap BR; Westenberg HG
    Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J; Koszycki D; Annable L; Couëtoux du Tertre A; Reines S; Karkanias C
    Biol Psychiatry; 1992 Nov; 32(10):903-12. PubMed ID: 1467375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.